US Stock MarketDetailed Quotes

GLPG Galapagos

Watchlist
  • 31.980
  • -0.970-2.94%
Trading Mar 28 15:12 ET
2.11BMarket Cap9.22P/E (TTM)

About Galapagos Company

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Company Profile

SymbolGLPG
Company NameGalapagos
Listing Date05/14/2015
Issue Price41.52
Founded1999
CEODr. Paulus Stoffels
MarketNASDAQ
Employees1338
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressIndustriepark Mechelen Noord,Generaal de Wittelaan L11 A3
CityMechelen
ProvinceBrussels Region
CountryBelgium
Zip Code2800
Phone32-1-534-29-00

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Paulus Stoffels
  • Chairman of the Supervisory Board and Chief Executive Officer
  • 1.47M
  • Bart Filius, M.B.A.
  • President, Chief Financial Officer and Chief Operating Officer
  • 2.81M
  • Walid Abi-Saab
  • Chief Medical Officer
  • 2.22M
  • Michele Manto
  • Chief Commercial Officer
  • 1.21M
  • Dr. Rajesh B. Parekh,D.Phil.
  • Member of the Supervisory Board
  • 146.34K
  • Jerome Contamine
  • Member of the Supervisory Board
  • 92.28K
  • Daniel O'Day
  • Member of the Supervisory Board
  • --
  • Peter Guenter
  • Member of the Supervisory Board
  • 115.54K
  • Mary Kerr
  • Member of the Supervisory Board
  • 115.53K
  • Dr. Linda Higgins, PhD
  • Member of the Supervisory Board
  • --
  • Dr. Elisabeth Svanberg
  • Member of the Supervisory Board
  • 100.53K
  • Daniel G. Baker
  • Member of the Supervisory Board
  • 68.43K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg